# Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy

> **NCT00840112** · NA · TERMINATED · sponsor: **Oregon Health and Science University** · enrollment: 1 (actual)

## Conditions studied

- Peripheral Neuropathy
- Mitochondrial Trifunctional Protein Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin E supplement

## Key facts

- **NCT ID:** NCT00840112
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-10
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** New data does not support a role of vitamin E in LCHAD associated neuropathy.
- **Last updated:** 2015-10-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00840112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00840112, "Vitamin E Treatment for Long-Chain 3-Hydroxyacyl Coenzyme A (CoA) Dehydrogenase (LCHAD) Associated Neuropathy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00840112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*